Kington attended the University of Michigan, where he received his B.S. with distinction and his M.D. After completing his residency
at Michael Reese Medical Center in Chicago,
he was appointed a Robert Wood Johnson clinical scholar at the University of Pennsylvania.
There he completed his M.B.A. with distinction
and his Ph.D. with a concentration in health policy and economics at the Wharton School and was awarded a Fontaine fellowship. In 2006, Kington was elected to membership in the Institute of Medicine of the National Academy
His research has focused on the role of social factors, especially socioeconomic status, as determinants of health.
On Nov. 12, Kington announced that NIDCR director Dr. Lawrence Tabak would become the new acting NIH principal deputy director. Tabak will continue to direct NIDCR and run a lab in NIDDK.
Tabak was appointed the seventh director of NIDCR in September 2000. As director, he leads a team of some 500 scientists, administrators and support staff with an annual budget of around $389 million.
Prior to joining NIH, Tabak was senior associate
dean for research and professor of dentistry
and biochemistry and biophysics in the School of Medicine and Dentistry at the University
He was elected a fellow of the AAAS and a member
of the Institute of Medicine of the National Academies. Tabak received his undergraduate degree from City College of the City University of New York, his D.D.S. from Columbia University,
and a Ph.D. from the State University of New York at Buffalo.
In other leadership changes, Dr. Norka Ruiz Bravo,
who had been NIH deputy director for extramural
research since October 2003, announced that she would transition to a new role as special
advisor to the NIH director. She recently
named Dr. Sherry Mills, who had been her senior policy advisor from 2005-2007 and OEP acting director, the OEP director.
As Ruiz Bravo changed roles, Dr. Sally Rockey,
who had been deputy director of the Office of Extramural Research for the past 3 years, became acting NIH deputy director for extramural
Implementing the next step of the NIH Reform Act, the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI) became a reality and Kington named Dr. Lana Skirboll acting director of what is colloquially known as “D-Poughkeepsie.” Skirboll had been director of the Office of Science Policy. DPCPSI is composed of four program and other offices. Filling in behind Skirboll as new acting director of OSP is Dr. Amy Patterson, who had directed the Office of Biotechnology Activities in OSP.
Finally, Dr. Alan Krensky, former OPASI director, is moving to an NCI laboratory and will also serve as senior advisor to the NIH deputy director.